Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: World J Surg. 2020 Jun;44(6):1824–1834. doi: 10.1007/s00268-020-05400-w

Table 7.

Post-operative complications and clinical outcomes

Variables, n (%) Total (n = 482) Pri-TC (n = 300) Pu-TC (n = 182) p Value
MOF* (SOFA*), day 2 71 (14.7) 52 (17.3) 19 (10.4) 0.27
Acute kidney injury 21 (4.4) 13 (4.3) 8 (4.4) 0.97
Adult respiratory distress syndrome 18 (3.7) 9 (3.0) 9 (4.9) 0.27
Bacteremia 31 (6.4) 19 (6.3) 12 (6.6) 0.91
Pneumonia 28 (5.8) 14 (4.7) 14 (7.7) 0.17
Sepsis or septic shock 34 (7.1) 18 (6.0) 16 (8.8) 0.25
Retained hemothorax 37 (7.7) 19 (6.3) 18 (9.9) 0.15
Empyema 26 (5.4) 13 (4.3) 13 (7.1) 0.19
Mediastinitis 8 (1.6) 6 (2.0) 2 (1.1) 0.45
ICU* length of stay, median (IQR*) 1 (0–5) 2 (0–6) 0 (0–2) <0.001
Hospital length of stay, median (IQR) 5 (1–12) 6 (1–13) 4 (1–12) 0.02
In-hospital mortality 212 (43.9) 116 (38.7) 96 (52.7) 0.003
 Mortality, first 24 h 186 (38.6) 106 (35.3) 80 (43.9) 0.25
 Mortality location, operating room 170 (80.6) 92 (79.3) 78 (82.1) 0.004
 Mortality location, ICU 35 (16.6) 24 (20.7) 11 (11.6)
 Mortality location, ward 6 (2.8) 0 (0) 6 (6.3)
Survival to discharge 270 (56.0) 184 (61.3) 86 (47.3) 0.003
Neurologically intact at discharge 210 (43.6) 134 (44.7) 76 (41.8) <0.001

Pri-TC Private Trauma Center, Pu-TC Public Trauma Center

*

MOF multiorgan failure, SOFA sequential organ failure assessment, ICU intensive care unit, IQR interquartile range